Abstract
Some anorectic drugs have been related with he development of heart valve lesions. Sibutramine is a new anorectic drug used for the treatment of obesity. Although data reported to date suggest that sibutramine does not induce heart valve lesions, there are no published reports performing longitudinal echocardiographic studies before and after treatment with sibutramine. Consecutive series of 16 obese patients who underwent Doppler-echocardiography before and after treatment with sibutramine. After 6 months of treatment, at 10 mg/day dose, sibutramine does noe appear to induce heart valve lesions. Sibutramine does not induce heart valve lesions when it is used in short-term treatment courses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.